- Home
- GAME vs MDAI Comparison
GAME vs MDAI Comparison
Compare GAME & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAME
- MDAI
- Stock Information
- Founded
- GAME 2011
- MDAI 2013
- Country
- GAME United States
- MDAI United States
- Employees
- GAME N/A
- MDAI N/A
- Industry
- GAME
- MDAI Medical/Dental Instruments
- Sector
- GAME
- MDAI Health Care
- Exchange
- GAME Nasdaq
- MDAI Nasdaq
- Market Cap
- GAME 23.4M
- MDAI 27.8M
- IPO Year
- GAME 2009
- MDAI N/A
- Fundamental
- Price
- GAME $0.75
- MDAI $1.27
- Analyst Decision
- GAME Strong Buy
- MDAI Strong Buy
- Analyst Count
- GAME 3
- MDAI 2
- Target Price
- GAME $3.67
- MDAI $4.75
- AVG Volume (30 Days)
- GAME 283.0K
- MDAI 308.8K
- Earning Date
- GAME 04-15-2025
- MDAI 05-06-2025
- Dividend Yield
- GAME N/A
- MDAI N/A
- EPS Growth
- GAME N/A
- MDAI N/A
- EPS
- GAME N/A
- MDAI N/A
- Revenue
- GAME $96,198,101.00
- MDAI $29,581,000.00
- Revenue This Year
- GAME $28.71
- MDAI N/A
- Revenue Next Year
- GAME $19.00
- MDAI $102.58
- P/E Ratio
- GAME N/A
- MDAI N/A
- Revenue Growth
- GAME 132.91
- MDAI 63.83
- 52 Week Low
- GAME $0.50
- MDAI $0.82
- 52 Week High
- GAME $1.67
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- GAME 49.75
- MDAI 46.06
- Support Level
- GAME $0.65
- MDAI $1.17
- Resistance Level
- GAME $0.79
- MDAI $1.34
- Average True Range (ATR)
- GAME 0.08
- MDAI 0.09
- MACD
- GAME 0.01
- MDAI 0.02
- Stochastic Oscillator
- GAME 59.04
- MDAI 50.92
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.